NVIV
InVivo Therapeutics Holdings Corp
NVIV
NVIV
Delisted
NVIV was delisted on the 12th of February, 2024.
25 hedge funds and large institutions have $2.17M invested in InVivo Therapeutics Holdings Corp in 2018 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
25
Holding in Top 10
–
Calls
$31K
Puts
–
Top Buyers
| 1 | +$113K | |
| 2 | +$102K | |
| 3 | +$86K | |
| 4 |
TSS
Two Sigma Securities
New York
|
+$40K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$30.2K |
Top Sellers
| 1 | -$255K | |
| 2 | -$163K | |
| 3 | -$91K | |
| 4 |
Goldman Sachs
New York
|
-$57K |
| 5 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$36K |